Repetitive acute intermittent hypoxia elicits respiratory metaplasticity
反复急性间歇性缺氧引起呼吸道化生
基本信息
- 批准号:8835755
- 负责人:
- 金额:$ 3.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-06-01 至 2017-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressBiologicalBrain-Derived Neurotrophic FactorBreathingCervicalChronicClinicalComplexCoupledCyclic AMPCyclic AMP-Dependent Protein KinasesDiseaseExposure toExtracellular Signal Regulated KinasesGTP-Binding ProteinsGeneticGoalsHumanHypoxiaIndividualMediatingMorbidity - disease rateMotorMotor Neuron DiseaseMotor outputNamesNerve DegenerationPathway interactionsPlasticsProtein IsoformsProtein Kinase CProteinsProto-Oncogene Proteins c-aktRattusReceptor ActivationReceptor InhibitionRehabilitation therapyResearchRespiratory InsufficiencySerotoninSignal TransductionSpinalSpinal InjuriesStimulusStudy modelsSystemTestingTherapeuticUrsidae Familyclinically significantinnovationmortalitymotor deficitnervous system disorderpreconditioningpublic health relevancereceptorrelating to nervous systemrespiratoryserotonin 7 receptortool
项目摘要
DESCRIPTION (provided by applicant): Plasticity and metaplasticity are hallmark features of the neural system controlling breathing. Respiratory plasticity is a persistent change in breathing
control following transient stimuli. Metaplasticity is a change in the capacity to express plasticiy (plastic plasticity). One well-studied model of respiratory plasticity is phrenic long- term facilitation (pLTF), a persistent increase in phrenic motor output following exposure to moderate acute intermittent hypoxia (AIH). Preconditioning with repetitive acute intermittent hypoxia (rAIH)
or chronic intermittent hypoxia (CIH) enhances pLTF, demonstrating a degree of respiratory metaplasticity. Multiple cellular mechanisms give rise to phenotypically similar long-lasting phrenic motor facilitation (pMF), including the so-called "Q" and "S" pathways to pMF. These pathways are named for the G proteins initiating plasticity. For example, moderate AIH-induced pLTF requires Gq-coupled 5-HT2 receptor activation, protein kinase C (PKC) activity, new synthesis of brain derived neurotrophic factor (BDNF) and downstream signaling via TrkB and ERK MAP kinases. Conversely, stimulation of Gs coupled 5-HT7 receptors activates cAMP, inducing new synthesis of an immature TrkB isoform and downstream protein kinase B/Akt activation. Normally, the Q and S pathways interact via mutual (cross-talk) inhibition. Thus, in normal rats, the dominant Q pathway to pLTF is constrained by sub-threshold S pathway activation (eg. by 5-HT7 receptor activation). The fundamental hypothesis guiding this proposal is that rAIH preconditioning elicits pLTF metaplasticity by reducing cross-talk inhibition between the S and Q pathways to pMF, thereby enhancing pLTF following moderate AIH by enabling independent contributions from both pathways. Thus, we predict that rAIH-enhanced pLTF (ie. metaplasticity) results from independent contributions from both 5-HT2 and 5-HT7 receptor activation. This research is significant from a biological perspective since it advances our understanding of basic mechanisms giving rise to respiratory motor plasticity and meta-plasticity. It is significant from a clinical perspective since rAIH has considerable therapeutic potential in debilitating clinical disorders that compromise respiratory and non-respiratory motor function.
描述(由申请人提供):可塑性和化塑性是控制呼吸的神经系统的标志特征。呼吸可塑性是呼吸的持续变化。
短暂刺激后的控制是表达可塑性(可塑性)的能力的变化,一种经过充分研究的呼吸可塑性模型是膈长期促进(pLTF),即暴露于中度急性刺激后膈运动输出的持续增加。间歇性缺氧(AIH)。反复急性间歇性缺氧(rAIH)。
慢性间歇性缺氧 (CIH) 会增强 pLTF,表明多种细胞机制会产生表型相似的持久膈运动易化 (pMF),包括所谓的 pMF 的“Q”和“S”途径。这些途径以启动可塑性的 G 蛋白命名,例如,中度 AIH 诱导的 pLTF 需要 Gq 偶联的 5-HT2 受体激活、蛋白激酶 C。 (PKC) 活性、脑源性神经营养因子 (BDNF) 的新合成和通过 TrkB 和 ERK MAP 激酶离线的下游信号传导、Gs 偶联 5-HT7 受体的刺激激活 cAMP,诱导未成熟的 TrkB 亚型和下游蛋白激酶的新合成。 B/Akt 激活通常情况下,Q 和 S 途径通过相互(串扰)抑制相互作用,因此,在正常大鼠中,pLTF 的主导 Q 途径受到限制。亚阈值 S 途径激活(例如通过 5-HT7 受体激活)指导该建议的基本假设是,rAIH 预处理通过减少 S 和 Q 途径与 pMF 之间的串扰抑制来引发 pLTF 化塑性,从而增强中度 AIH 后的 pLTF。因此,我们预测 rAIH 增强的 pLTF(即化塑性)是由 5-HT2 和 5-HT7 受体的独立贡献引起的。从生物学角度来看,这项研究具有重要意义,因为它增进了我们对引起呼吸运动可塑性和后可塑性的基本机制的理解。从临床角度来看,rAIH 在损害呼吸和运动能力的衰弱临床疾病方面具有相当大的治疗潜力。非呼吸运动功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daryl Fields其他文献
Daryl Fields的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
An Integrated Model of Contextual Safety, Social Safety, and Social Vigilance as Psychosocial Contributors to Cardiovascular Disease
情境安全、社会安全和社会警惕作为心血管疾病社会心理因素的综合模型
- 批准号:
10749134 - 财政年份:2024
- 资助金额:
$ 3.28万 - 项目类别:
Next Generation Opto-GPCRs for Neuromodulatory Control
用于神经调节控制的下一代 Opto-GPCR
- 批准号:
10515612 - 财政年份:2023
- 资助金额:
$ 3.28万 - 项目类别:
Investigating the Effect of FLASH-Radiotherapy on Tumor and Normal Tissue
研究 FLASH 放射治疗对肿瘤和正常组织的影响
- 批准号:
10650476 - 财政年份:2023
- 资助金额:
$ 3.28万 - 项目类别:
Clonal hematopoiesis and inherited genetic variation in sickle cell disease
镰状细胞病的克隆造血和遗传变异
- 批准号:
10638404 - 财政年份:2023
- 资助金额:
$ 3.28万 - 项目类别:
Developing Therapeutic Gel Embolic Agents for Arteriovenous Malformation Embolization
开发用于动静脉畸形栓塞治疗的凝胶栓塞剂
- 批准号:
10667726 - 财政年份:2023
- 资助金额:
$ 3.28万 - 项目类别: